Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Statistics

Total Valuation

SGMT has a market cap or net worth of $216.92 million. The enterprise value is $91.54 million.

Market Cap	216.92M
Enterprise Value	91.54M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

SGMT has 32.52 million shares outstanding. The number of shares has increased by 10.81% in one year.

Current Share Class	31.00M
Shares Outstanding	32.52M
Shares Change (YoY)	+10.81%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	7.43%
Owned by Institutions (%)	39.59%
Float	25.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.82
P/TBV Ratio	1.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.06, with a Debt / Equity ratio of 0.00.

Current Ratio	13.06
Quick Ratio	12.76
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -39.78% and return on invested capital (ROIC) is -27.71%.

Return on Equity (ROE)	-39.78%
Return on Assets (ROA)	-26.52%
Return on Invested Capital (ROIC)	-27.71%
Return on Capital Employed (ROCE)	-53.93%
Revenue Per Employee	n/a
Profits Per Employee	-$4.12M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.57% in the last 52 weeks. The beta is 3.31, so SGMT's price volatility has been higher than the market average.

Beta (5Y)	3.31
52-Week Price Change	+47.57%
50-Day Moving Average	7.54
200-Day Moving Average	6.08
Relative Strength Index (RSI)	37.53
Average Volume (20 Days)	524,316

Short Selling Information

The latest short interest is 3.13 million, so 9.62% of the outstanding shares have been sold short.

Short Interest	3.13M
Short Previous Month	2.75M
Short % of Shares Out	9.62%
Short % of Float	12.42%
Short Ratio (days to cover)	5.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-64.32M
Pretax Income	-57.67M
Net Income	-57.67M
EBITDA	n/a
EBIT	-64.32M
Earnings Per Share (EPS)	-$1.79

Balance Sheet

The company has $116.69 million in cash and $115,000 in debt, giving a net cash position of $125.38 million or $3.86 per share.

Cash & Cash Equivalents	116.69M
Total Debt	115,000
Net Cash	125.38M
Net Cash Per Share	$3.86
Equity (Book Value)	119.26M
Book Value Per Share	3.67
Working Capital	110.33M

Cash Flow

Operating Cash Flow	-44.84M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SGMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.81%
Shareholder Yield	-10.81%
Earnings Yield	-26.59%
FCF Yield	n/a

Analyst Forecast

The average price target for SGMT is $29.75, which is 346.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.75
Price Target Difference	346.03%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-3.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1